Neurocrine Biosciences, Inc. NBIX
165.43 USD +0.12 (+0.07%)
As ofNov 17, 2026, 1:52 PM EST
161.99 Day range 166.25
123.10 52-week range 185.50
- YTD
- +16.64%
- 1 year
- +15.23%
NBIX revenue history
Revenue is income from the company’s ordinary business activities.
2,860,500,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,860,500,000 | 505,200,000 | 21.45% |
| FY 2024 | 2024-12-31 | 2,355,300,000 | 468,200,000 | 24.81% |
| FY 2023 | 2023-12-31 | 1,887,100,000 | 398,400,000 | 26.76% |
| FY 2022 | 2022-12-31 | 1,488,700,000 | 355,200,000 | 31.34% |
| FY 2021 | 2021-12-31 | 1,133,500,000 | 87,600,000 | 8.38% |
| FY 2020 | 2020-12-31 | 1,045,900,000 | 257,800,000 | 32.71% |
| FY 2019 | 2019-12-31 | 788,100,000 | 336,900,000 | 74.67% |
| FY 2018 | 2018-12-31 | 451,200,000 | 289,574,000 | 179.16% |
| FY 2017 | 2017-12-31 | 161,626,000 | 146,626,000 | 977.51% |
| FY 2016 | 2016-12-31 | 15,000,000 | -4,769,000 | -24.12% |
| FY 2015 | 2015-12-31 | 19,769,000 | 19,769,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | -2,919,000 | -100.00% |
| FY 2013 | 2013-12-31 | 2,919,000 | -50,221,000 | -94.51% |
| FY 2012 | 2012-12-31 | 53,140,000 | -24,273,000 | -31.36% |
| FY 2011 | 2011-12-31 | 77,413,000 | 43,912,000 | 131.08% |
| FY 2010 | 2010-12-31 | 33,501,000 | 30,548,000 | 1034.47% |
| FY 2009 | 2009-12-31 | 2,953,000 | -1,022,000 | -25.71% |
| FY 2008 | 2008-12-31 | 3,975,000 | 2,751,000 | 224.75% |
| FY 2007 | 2007-12-31 | 1,224,000 | -38,010,000 | -96.88% |
| FY 2006 | 2006-12-31 | 39,234,000 | -84,655,000 | -68.33% |
| FY 2005 | 2005-12-31 | 123,889,000 | 38,713,000 | 45.45% |
| FY 2004 | 2004-12-31 | 85,176,000 | -53,902,000 | -38.76% |
| FY 2003 | 2003-12-31 | 139,078,000 | 121,033,000 | 670.73% |
| FY 2002 | 2002-12-31 | 18,045,000 | -23,197,000 | -56.25% |
| FY 2001 | 2001-12-31 | 41,242,000 | 26,654,000 | 182.71% |
| FY 2000 | 2000-12-31 | 14,588,000 | -2,203,000 | -13.12% |
| FY 1999 | 1999-12-31 | 16,791,000 | 754,000 | 4.70% |
| FY 1998 | 1998-12-31 | 16,037,000 | -10,107,000 | -38.66% |
| FY 1997 | 1997-12-31 | 26,144,000 | 6,928,000 | 36.05% |
| FY 1996 | 1996-12-31 | 19,216,000 | 13,110,250 | 214.72% |
| FY 1995 | 1995-12-31 | 6,105,750 | 5,944,217 | 3679.88% |
| FY 1994 | 1994-12-31 | 161,533 | 161,533 | Not meaningful |
| FY 1993 | 1993-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
